Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Policy + Initiatives

DOE Providing Funding and Expertise for Researchers to Support COVID-19 Projects

by Global Biodefense Staff
November 5, 2020

Credit: NIAID

The U.S. Department of Energy’s (DOE) Office of Technology Transitions (OTT) has announced a COVID-19 Technical Assistance Program (CTAP) that provides funding for national laboratory researchers to assist U.S. entities on COVID-19 projects.

The DOE National Laboratories have unique capabilities, facilities and tools, enabling them to provide technical services, analysis, testing, and consulting to external parties.

Eligibility is limited to projects providing COVID-19-related technical assistance to U.S. entities, defined as entities that are not subject to foreign majority control.

Parties interested in applying for CTAP funding should contact partners@​anl.​gov.

CTAP funding is for technical assistance of limited duration/scope (projects up to 40 full-time-employee hours are considered appropriate). Projects exceeding that threshold will require justification.

CTAP-funded projects are not meant to be research-and-development intensive, nor are they intended to generate intellectual property.

Tags: BiotechnologyCOVID-19Editor PickInnovationSARS-CoV-2Tech Transfer

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy